Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Hepatitis C

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 97 articles: HTML format

Single Articles

June 2008
1. OSNA NA , White RL, Krutik VM, Wang T, et al
   Proteasome activation by hepatitis C core protein is reversed by ethanol-induced oxidative stress.
   Gastroenterology. 2008;134:2144-52.
   PubMed     Related articles    Abstract available
   
   
   
2. NAKAMOTO N , Kaplan DE, Coleclough J, Li Y, et al
   Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
   Gastroenterology. 2008;134:1927-37.
   PubMed     Related articles    Abstract available
   
   
   May 2008
3. FERENCI P , Laferl H, Scherzer TM, Gschwantler M, et al
   Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response.
   Gastroenterology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. TILLMANN HL , Patel K, McHutchison JG
   GBV-C in HIV-HCV Coinfection, Low Liver-Related Mortality But High Overall Mortality.
   Gastroenterology. 2008;.
   PubMed     Related articles   
   
   
   
5. DAYYEH BK , Chung RT
   Broadly Neutralizing Antibodies Against Hepatitis C Virus: New Hope for Immunization?
   Gastroenterology. 2008;.
   PubMed     Related articles   
   
   
   
6. MUKHERJEE S , Sorrell MF
   Controversies in liver transplantation for hepatitis C.
   Gastroenterology. 2008;134:1777-88.
   PubMed     Related articles    Abstract available
   
   
   
7. MISSIHA SB , Ostrowski M, Heathcote EJ
   Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.
   Gastroenterology. 2008;134:1699-714.
   PubMed     Related articles    Abstract available
   
   
   
8. MARTINI F , Sacchi A, Lalle E, Castilletti C, et al
   GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.
   Gastroenterology. 2008;134:1631-3.
   PubMed     Related articles   
   
   
   
9. FERRARI C
   Therapeutic vaccination for hepatitis C: can protective T-cell responses be restored after prolonged antigen exposure?
   Gastroenterology. 2008;134:1601-4.
   PubMed     Related articles   
   
   
   
10. KLADE CS , Wedemeyer H, Berg T, Hinrichsen H, et al
    Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
    Gastroenterology. 2008;134:1385-95.
    PubMed     Related articles    Abstract available
    
    
    
11. ASAHINA Y , Izumi N, Hirayama I, Tanaka T, et al
    Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response.
    Gastroenterology. 2008;134:1396-405.
    PubMed     Related articles    Abstract available
    
    
    March 2008
12. BALAGOPAL A , Philp FH, Astemborski J, Block TM, et al
    Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C.
    Gastroenterology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. BORTOLOTTI F , Verucchi G, Camma C, Cabibbo G, et al
    Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease.
    Gastroenterology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. LIN W , Weinberg EM, Tai AW, Peng LF, et al
    HIV Increases HCV Replication in a TGF-beta1-Dependent Manner.
    Gastroenterology. 2008;134:803-11.
    PubMed     Related articles    Abstract available
    
    
    February 2008
15. PUNGPAPONG S , Kim WR
    Mortality in patients with hepatitis C.
    Gastroenterology. 2008;134:635-7.
    PubMed     Related articles   
    
    
    
16. NEUSCHWANDER-TETRI BA
    Hepatitis C virus-induced insulin resistance: not all genotypes are the same.
    Gastroenterology. 2008;134:619-22.
    PubMed     Related articles   
    
    
    
17. HEZODE C , Zafrani ES, Roudot-Thoraval F, Costentin C, et al
    Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
    Gastroenterology. 2008;134:432-9.
    PubMed     Related articles    Abstract available
    
    
    
18. KUNOS G , Gao B
    Endocannabinoids, CB1 receptors, and liver disease: hitting more than one bird with the same stone.
    Gastroenterology. 2008;134:622-5.
    PubMed     Related articles   
    
    
    January 2008
19. OTON E , Barcena R
    Severe hepatitis C recurrence: is it a negative predictive factor for sustained response to treatment?
    Gastroenterology. 2008;134:367.
    PubMed     Related articles   
    
    
    
20. TRINDER D , Ayonrinde OT, Olynyk JK
    HCV, iron, and oxidative stress: the new choreography of hepcidin.
    Gastroenterology. 2008;134:348-51.
    PubMed     Related articles   
    
    
    
21. NISHINA S , Hino K, Korenaga M, Vecchi C, et al
    Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
    Gastroenterology. 2008;134:226-38.
    PubMed     Related articles    Abstract available
    
    
    December 2007
22. PHAM TN , King D, Macparland SA, McGrath JS, et al
    Hepatitis C Virus Replicates in the Same Immune Cell Subsets in Chronic Hepatitis C and Occult Infection.
    Gastroenterology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. VIGANO M , Aghemo A, Iavarone M
    The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis.
    Gastroenterology. 2007;133:2076.
    PubMed     Related articles   
    
    
    
24. COREY KE , Chung RT
    Treating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelope.
    Gastroenterology. 2007;133:2062-3.
    PubMed     Related articles   
    
    
    
25. STAPLETON J
    A new variable influencing HCV-related liver disease in HIV-HCV coinfected individuals?
    Gastroenterology. 2007;133:2042-5.
    PubMed     Related articles   
    
    
    
26. BERZSENYI MD , Bowden DS, Kelly HA, Watson KM, et al
    Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection.
    Gastroenterology. 2007;133:1821-30.
    PubMed     Related articles    Abstract available
    
    
    November 2007
27. MOUCARI R , Asselah T, Cazals-Hatem D, Voitot H, et al
    Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis.
    Gastroenterology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. KIM AY , Chung RT
    Sex, drugs, and hepatitis C virus in men who have sex with men: evidence for permucosal transmission.
    Gastroenterology. 2007;133:1734-6.
    PubMed     Related articles   
    
    
    
29. ZHU H , Dong H, Eksioglu E, Hemming A, et al
    Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Gastroenterology. 2007;133:1649-59.
    PubMed     Related articles    Abstract available
    
    
    
30. GOTTWEIN JM , Scheel TK, Hoegh AM, Lademann JB, et al
    Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gastroenterology. 2007;133:1614-26.
    PubMed     Related articles    Abstract available
    
    
    October 2007
31. NAHON P , Sutton A, Rufat P, Ziol M, et al
    Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis.
    Gastroenterology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. SHAN Y , Zheng J, Lambrecht RW, Bonkovsky HL, et al
    Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes.
    Gastroenterology. 2007;133:1166-74.
    PubMed     Related articles    Abstract available
    
    
    
33. VANWOLLEGHEM T , Meuleman P, Libbrecht L, Roskams T, et al
    Ultra-Rapid Cardiotoxicity of the Hepatitis C Virus Protease Inhibitor BILN 2061 in the Urokinase-Type Plasminogen Activator Mouse.
    Gastroenterology. 2007;133:1144-55.
    PubMed     Related articles    Abstract available
    
    
    
34. PILLI M , Zerbini A, Penna A, Orlandini A, et al
    HCV-Specific T-Cell Response in Relation to Viral Kinetics and Treatment Outcome (DITTO-HCV Project).
    Gastroenterology. 2007;133:1132-43.
    PubMed     Related articles    Abstract available
    
    
    September 2007
35. TAI AW , Chung RT
    The hepatitis C virus plot thickens: enter claudin-1.
    Gastroenterology. 2007;133:1041-2.
    PubMed     Related articles   
    
    
    August 2007
36. DOLGANIUC A , Norkina O, Kodys K, Catalano D, et al
    Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV Infection.
    Gastroenterology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. LANG L
    Hepatitis C virus-infected donors in liver transplantation.
    Gastroenterology. 2007;133:381-2.
    PubMed     Related articles   
    
    
    July 2007
38. VIGANO M , Lampertico P, Rumi MG, Folli C, et al
    Natural History and Clinical Impact of Cryoglobulins in Chronic Hepatitis C: 10-Year Prospective Study of 343 Patients.
    Gastroenterology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
39. LANG L
    Interim Results Presented at EASL From PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C.
    Gastroenterology. 2007;132:2283-4.
    PubMed     Related articles   
    
    
    
40. LANG L
    HCV Findings Presented at EASL: Long-Term Follow-Up and the Criteria of a Cure.
    Gastroenterology. 2007;132:2282-3.
    PubMed     Related articles   
    
    
    May 2007
41. PERELSON AS , Layden TJ
    Ribavirin: is it a mutagen for hepatitis C virus?
    Gastroenterology. 2007;132:2050-2.
    PubMed     Related articles   
    
    
    
42. PAWLOTSKY JM , Chevaliez S, McHutchison JG
    The hepatitis C virus life cycle as a target for new antiviral therapies.
    Gastroenterology. 2007;132:1979-98.
    PubMed     Related articles    Abstract available
    
    
    
43. POLYAK SJ , Morishima C, Shuhart MC, Wang CC, et al
    Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized silymarin.
    Gastroenterology. 2007;132:1925-36.
    PubMed     Related articles    Abstract available
    
    
    
44. SARRAZIN C , Kieffer TL, Bartels D, Hanzelka B, et al
    Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.
    Gastroenterology. 2007;132:1767-77.
    PubMed     Related articles    Abstract available
    
    
    
45. LUTCHMAN G , Danehower S, Song BC, Liang TJ, et al
    Mutation Rate of the Hepatitis C Virus NS5B in Patients Undergoing Treatment With Ribavirin Monotherapy.
    Gastroenterology. 2007;132:1757-66.
    PubMed     Related articles    Abstract available
    
    
    
46. CARRION JA , Navasa M, Garcia-Retortillo M, Garcia-Pagan JC, et al
    Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.
    Gastroenterology. 2007;132:1746-56.
    PubMed     Related articles    Abstract available
    
    
    April 2007
47. PAWLOTSKY JM
    Treatment of Hepatitis C: Don't Put All Your Eggs in One Basket!
    Gastroenterology. 2007;.
    PubMed     Related articles   
    
    
    
48. LAUER GM , Chung RT
    Vaccine induced T-CELL responses against HCV: One step taken, more to follow.
    Gastroenterology. 2007;.
    PubMed     Related articles   
    
    
    
49. DI MARCO V , Bronte F, Capra M, Gerardi C, et al
    HCV Clearance Among Hemophiliacs.
    Gastroenterology. 2007;.
    PubMed     Related articles   
    
    
    March 2007
50. DE RE V , Caggiari L, Simula MP, de Vita S, et al
    B-cell lymphomas associated with HCV infection.
    Gastroenterology. 2007;132:1205-7.
    PubMed     Related articles   
    
    
    
51. HOFMANN WP , Polta A, Herrmann E, Mihm U, et al
    Mutagenic Effect of Ribavirin on Hepatitis C Nonstructural 5B Quasispecies In Vitro and During Antiviral Therapy.
    Gastroenterology. 2007;132:921-30.
    PubMed     Related articles    Abstract available
    
    
    
52. BROWN R JR , Emond JC
    Managing access to liver transplantation: implications for gastroenterology practice.
    Gastroenterology. 2007;132:1152-63.
    PubMed     Related articles   
    
    
    February 2007
53. KRAUS MR , Al-Taie O, Schafer A, Pfersdorff M, et al
    Serotonin-1A Receptor Gene HTR1A Variation Predicts Interferon-Induced Depression in Chronic Hepatitis C.
    Gastroenterology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
54. FERRARI CA
    T and B Cells in Hepatitis C Virus Control: What They Do and When They Fail.
    Gastroenterology. 2007;.
    PubMed     Related articles   
    
    
    
55. SARRAZIN C , Rouzier R, Wagner F, Forestier N, et al
    SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon alpha-2b for Genotype 1 Nonresponders.
    Gastroenterology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. KIM SS , Peng LF, Lin W, Choe WH, et al
    A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication.
    Gastroenterology. 2007;132:311-20.
    PubMed     Related articles    Abstract available
    
    
    
57. SHIFFMAN ML , Ghany MG, Morgan TR, Wright EC, et al
    Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
    Gastroenterology. 2007;132:103-12.
    PubMed     Related articles    Abstract available
    
    
    
58. LANG L
    Combination therapy with telaprevir and pegylated interferon suppresses both wild-type and resistant hepatitis C virus.
    Gastroenterology. 2007;132:5-6.
    PubMed     Related articles   
    
    
    December 2006
59. VON HAHN T , Yoon JC, Alter H, Rice CM, et al
    Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo.
    Gastroenterology. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
60. CHANG KM
    Hepatitis C: a new horizon.
    Gastroenterology. 2006;131:1667-8.
    PubMed     Related articles   
    
    
    November 2006
61. KAPLAN DE , Sugimoto K, Newton K, Valiga ME, et al
    Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C.
    Gastroenterology. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
62. HUANG Y , Feld JJ, Sapp RK, Nanda S, et al
    Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C.
    Gastroenterology. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
63. ALOMAN C , Gehring S, Wintermeyer P, Kuzushita N, et al
    Chronic Ethanol Consumption Impairs Cellular Immune Responses Against HCV NS5 Protein Due to Dendritic Cell Dysfunction.
    Gastroenterology. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
64. RANDALL G , Chen L, Panis M, Fischer AK, et al
    Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection.
    Gastroenterology. 2006;131:1584-91.
    PubMed     Related articles    Abstract available
    
    
    
65. HENRY SD , Metselaar HJ, Lonsdale RC, Kok A, et al
    Mycophenolic Acid Inhibits Hepatitis C Virus Replication and Acts in Synergy With Cyclosporin A and Interferon-alpha.
    Gastroenterology. 2006;131:1452-62.
    PubMed     Related articles    Abstract available
    
    
    
66. BONKOVSKY HL , Naishadham D, Lambrecht RW, Chung RT, et al
    Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C.
    Gastroenterology. 2006;131:1440-51.
    PubMed     Related articles    Abstract available
    
    
    October 2006
67. ALEXANDER J , Kowdley KV
    Effects of Iron and HFE Mutations on Response to Therapy in Chronic Hepatitis C: An Ironic Interaction?
    Gastroenterology. 2006;.
    PubMed     Related articles   
    
    
    
68. SHIFFMAN ML , Rustgi VK
    Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough.
    Gastroenterology. 2006;131:1339-41.
    PubMed     Related articles   
    
    
    
69. BRONOWICKI JP , Ouzan D, Asselah T, Desmorat H, et al
    Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
    Gastroenterology. 2006;131:1040-8.
    PubMed     Related articles    Abstract available
    
    
    
70. REESINK HW , Zeuzem S, Weegink CJ, Forestier N, et al
    Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study.
    Gastroenterology. 2006;131:997-1002.
    PubMed     Related articles    Abstract available
    
    
    
71. MARCELLO T , Grakoui A, Barba-Spaeth G, Machlin ES, et al
    Interferons alpha and lambda Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics.
    Gastroenterology. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
72. NIETERS A , Kallinowski B, Brennan P, Ott M, et al
    Hepatitis C and Risk of Lymphoma: Results of the European Multicenter Case-Control Study Epilymph.
    Gastroenterology. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
73. LLOVET JM , Chen Y, Wurmbach E, Roayaie S, et al
    A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis.
    Gastroenterology. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
74. FERENCI P
    The host or the virus? Impact of genetic factors on the outcome of hepatitis C virus infection.
    Gastroenterology. 2006;131:954-6.
    PubMed     Related articles   
    
    
    
75. FRIED MW , Kroner BL, Preiss LR, Wilhelmsen K, et al
    Hemophilic siblings with chronic hepatitis C: familial aggregation of spontaneous and treatment-related viral clearance.
    Gastroenterology. 2006;131:757-64.
    PubMed     Related articles    Abstract available
    
    
    August 2006
76. BRUNI L , De Sanjose S
    Hepatitis C Infection and Lymphomas: Is There any Benefit in Viral Treatment?
    Gastroenterology. 2006;131:685-686.
    PubMed     Related articles   
    
    
    
77. MALNICK SD , Basevitch A
    Peginterferon alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response.
    Gastroenterology. 2006;131:683.
    PubMed     Related articles   
    
    
    
78. WEDEMEYER H , Cornberg M, Wiegand J, Jackel E, et al
    Treatment of acute hepatitis C-how to explain the differences?
    Gastroenterology. 2006;131:682-3.
    PubMed     Related articles   
    
    
    
79. NAINAN OV , Alter MJ, Kruszon-Moran D, Gao FX, et al
    Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Gastroenterology. 2006;131:478-84.
    PubMed     Related articles    Abstract available
    
    
    
80. CONJEEVARAM HS , Fried MW, Jeffers LJ, Terrault NA, et al
    Peginterferon and ribavirin treatment in african american and caucasian american patients with hepatitis C genotype 1.
    Gastroenterology. 2006;131:470-7.
    PubMed     Related articles    Abstract available
    
    
    
81. SANCHEZ-TAPIAS JM , Diago M, Escartin P, Enriquez J, et al
    Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment.
    Gastroenterology. 2006;131:451-460.
    PubMed     Related articles    Abstract available
    
    
    July 2006
82. SJOGREN MH
    Management of hepatitis C.
    Gastroenterology. 2006;131:332.
    PubMed     Related articles   
    
    
    
83. DI LIBERTO G , Roque-Afonso AM, Kara R, Ducoulombier D, et al
    Clinical and therapeutic implications of hepatitis C virus compartmentalization.
    Gastroenterology. 2006;131:76-84.
    PubMed     Related articles    Abstract available
    
    
    
84. LANG L
    US Prevalence of HCV Infection Remains Substantial.
    Gastroenterology. 2006;131:7-8.
    PubMed     Related articles   
    
    
    June 2006
85. EVERHART JE
    Alcohol and hepatitis C: do we have a drinking problem?
    Gastroenterology. 2006;130:1912-4.
    PubMed     Related articles   
    
    
    
86. HUANG H , Shiffman ML, Cheung RC, Layden TJ, et al
    Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
    Gastroenterology. 2006;130:1679-87.
    PubMed     Related articles    Abstract available
    
    
    
87. MIRANDOLA S , Realdon S, Iqbal J, Gerotto M, et al
    Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Gastroenterology. 2006;130:1661-9.
    PubMed     Related articles    Abstract available
    
    
    
88. LEANDRO G , Mangia A, Hui J, Fabris P, et al
    Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data.
    Gastroenterology. 2006;130:1636-1642.
    PubMed     Related articles    Abstract available
    
    
    
89. ANAND BS , Currie S, Dieperink E, Bini EJ, et al
    Alcohol use and treatment of hepatitis C virus: results of a national multicenter study.
    Gastroenterology. 2006;130:1607-16.
    PubMed     Related articles    Abstract available
    
    
    
90. MUELLER S , Afdhal NH, Schuppan D
    Iron, HCV, and liver cancer: hard metal setting the pace?
    Gastroenterology. 2006;130:2229-34.
    PubMed     Related articles   
    
    
    
91. PARADIS V , Asselah T, Dargere D, Ripault MP, et al
    Serum Proteome to Predict Virologic Response in Patients With Hepatitis C Treated by Pegylated Interferon Plus Ribavirin.
    Gastroenterology. 2006;130:2189-2197.
    PubMed     Related articles    Abstract available
    
    
    
92. FURUTANI T , Hino K, Okuda M, Gondo T, et al
    Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Gastroenterology. 2006;130:2087-98.
    PubMed     Related articles    Abstract available
    
    
    April 2006
93. FONTANA RJ
    Optimizing outcomes in hepatitis C: is treatment beyond 48 weeks ever justified?
    Gastroenterology. 2006;130:1357-62.
    PubMed     Related articles   
    
    
    
94. PAL S , Sullivan DG, Kim S, Lai KK, et al
    Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.
    Gastroenterology. 2006;130:1107-16.
    PubMed     Related articles    Abstract available
    
    
    
95. BERG T , von Wagner M, Nasser S, Sarrazin C, et al
    Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.
    Gastroenterology. 2006;130:1086-97.
    PubMed     Related articles    Abstract available
    
    
    
96. TALIANI G , Gemignani G, Ferrari C, Aceti A, et al
    Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients.
    Gastroenterology. 2006;130:1098-106.
    PubMed     Related articles    Abstract available
    
    
    July 2005
97. BLENDIS L
    Delayed treatment of acute hepatitis HCV? Yes, but when, who, and how?
    Gastroenterology. 2005;129:390-1.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: